ACIONT, INC.

Basic Information

350 WEST 800 NORTH, STE 320
SALT LAKE CITY, UT, 84103-

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Non-Invasive Treatment for Uveitis

    Amount: $2,029,592.00

    DESCRIPTION (provided by applicant): The aim of this innovative proposal is to commercialize a non-invasive topical product that treats uveitis which is safe and easy to administer. Uveitis is the thi ...

    SBIR Phase II 2013 Department of Health and Human Services
  2. Non-Invasive Drug Delivery to Treat Posterior Uveitis

    Amount: $133,202.00

    Intermediate and posterior uveitis cause 10% of blindness in the U.S. The mainstay of therapy is to eradicate the infectious cause and to quell the inflammation with corticosteroids or immunosuppressa ...

    SBIR Phase I 2004 Department of Health and Human Services
  3. NON-INVASIVE BLOOD PHENYLALANINE MONITOR

    Amount: $159,509.00

    DESCRIPTION (provided by applicant): Phenylketonuria (PKU) is a genetic deficiency of phenylalanine hydroxylase (PAH). Without PAH, the patient with PKU cannot metabolize phenylalanine (PHE) to tyros ...

    SBIR Phase I 2002 Department of Health and Human Services
  4. IMPROVED NON-INVASIVE BLOOD GLUCOSE MONITORING DEVICE

    Amount: $140,992.00

    The accurate measurement of blood glucose concentration is important in the management of diabetes. Current methods of glucose monitoring involve piercing the skin and collecting blood samples for ana ...

    SBIR Phase I 2002 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government